Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 318,043 | 610,018 | 535,842 | 415,676 | 230,155 |
| Marketable Securities | 255,678 | 40,653 | 46,746 | 34,659 | 42,649 |
| Receivables | 211,174 | 122,255 | 130,668 | 157,075 | 178,563 |
| Inventories | 393,393 | 399,588 | 375,798 | 364,740 | 348,773 |
| Income taxes - deferred | 106,640 | 89,259 | 96,074 | 81,959 | 77,416 |
| TOTAL | $1,323,489 | $1,291,740 | $1,206,726 | $1,081,896 | $913,451 |
| Non-Current Assets | |||||
| PPE Net | 424,995 | 384,620 | 340,776 | 317,880 | 304,667 |
| Investments And Advances | 50,096 | 72,623 | 85,181 | 83,462 | 75,435 |
| Intangibles | 1,456,890 | 1,460,347 | 1,477,334 | 1,495,118 | 1,335,315 |
| Other Non-Current Assets | 27,130 | 31,478 | 33,563 | 33,919 | 34,596 |
| TOTAL | $1,959,111 | $1,949,068 | $1,936,854 | $1,930,379 | $1,750,013 |
| Total Assets | $3,282,600 | $3,240,808 | $3,143,580 | $3,012,275 | $2,663,464 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 83,360 |
| Accounts payable and accrued liabilities | 215,388 | 209,703 | 209,391 | 200,457 | 172,363 |
| Other current liabilities | N/A | N/A | 1,718 | 1,719 | N/A |
| TOTAL | $338,685 | $351,925 | $330,669 | $285,597 | $375,465 |
| Non-Current Liabilities | |||||
| Long Term Debt | 722,535 | 722,427 | 722,320 | 722,426 | 331,877 |
| Deferred Revenues | 11,315 | 10,965 | N/A | N/A | 8,177 |
| aiOther Non-Current Liabilities | 9,641 | 9,938 | 9,881 | 7,881 | 5,948 |
| TOTAL | $886,569 | $893,076 | $882,664 | $872,559 | $489,715 |
| Total Liabilities | $1,225,254 | $1,245,001 | $1,213,333 | $1,158,156 | $865,180 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 108,699 | 107,954 | 107,734 | 107,057 | 106,941 |
| Common Shares | 357 | 356 | 355 | 353 | 353 |
| Retained earnings | 1,201,714 | 1,148,853 | 1,097,394 | 1,046,679 | 998,850 |
| Other shareholders' equity | 14,268 | 18,580 | 18,191 | 8,020 | 1,984 |
| TOTAL | $2,057,346 | $1,995,807 | $1,930,247 | $1,854,119 | $1,798,284 |
| Total Liabilities And Equity | $3,282,600 | $3,240,808 | $3,143,580 | $3,012,275 | $2,663,464 |